Biocon — Fact Sheet (September 2015)

5 slides from Biocon's fact sheet, September 2015

Slide 1: Biocon Group Fact Sheet September 2015
BIOCON GROUP FACT SHEET September - 2015
Slide 2: Biocon Limited (Consolidated) Balance Sheet
BIOCON LIMITED (CONSOLIDATED) BALANCE SHEET (Rs. Crore) Sept 30, 2015 March 31, 2015 EQUITY AND LIABILITIES Shareholder's Funds (a) Share capital 100 100 (b)Reserves and surplus 3,526 3,171 3,626 3,271 Minority interest 308 172 Non-current liabilities (a) Long-term borrowings 878 770 (b)Deferred tax
Slide 3: Profit & Loss Statement H1 FY16 vs H1 FY15
BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crore) H1 H1 Particulars FY 16 FY 15 Variance INCOME Biopharmaceuticals 1,179 1,103 7% Biopharma * 948 877 8% Branded formulations - India 231 226 2% Contract research 474 365 30% Total Sales 1,653 1,468 13% Other income 65 47 41% TOTAL REVE
Slide 4: Profit & Loss Statement Q2 FY16 vs Q1 FY16
BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crore) Q2 Q1 Particulars FY 16 FY 16 Variance INCOME Biopharmaceuticals 578 601 -4% Biopharma * 459 489 -6% Branded formulations - India 119 112 6% Contract research 250 224 12% Total Sales 828 825 1% Other income 33 32 5% TOTAL REVENUE 861
Slide 5: Profit & Loss Statement Q2 FY16 vs Q2 FY15
BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crore) Q2 Q2 Particulars FY 16 FY 15 Variance INCOME Biopharmaceuticals 578 558 4% Biopharma * 459 442 4% Branded formulations - India 119 116 3% Contract research 250 192 30% Total Sales 828 750 11% Other income 33 23 45% TOTAL REVENUE 861